Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Piper Sandler analyst Biren Amin initiated coverage on Perspective Therapeutics Inc (AMEX:CATX) with an Overweight rating and announced a price target of $16. Perspective Therapeutics shares closed at $5.03 on Wednesday. See how other analysts view this stock.
- Mizuho analyst Bradley Bowers initiated coverage on Tempus AI Inc (NASDAQ:TEM) with an Outperform rating and announced a price target of $100. Tempus AI shares closed at $56.16 on Wednesday. See how other analysts view this stock.
- Freedom Capital Markets analyst Dmitriy Pozdnyakov initiated coverage on Gentherm Inc (NASDAQ:THRM) with a Buy rating and announced a price target of $41. Gentherm shares closed at $30.91 on Wednesday. See how other analysts view this stock.
- Roth Capital analyst Sean McGowan initiated coverage on Bioharvest Sciences Inc (NASDAQ:BHST) with a Buy rating and announced a price target of $10. BioHarvest Sciences shares closed at $4.44 on Wednesday. See how other analysts view this stock.
- Wells Fargo analyst Larry Biegelsen initiated coverage on AxoGen, Inc (NASDAQ:AXGN) with an Overweight rating and announced a price target of $40. Axogen shares closed at $35.25 on Wednesday. See how other analysts view this stock.
Considering buying TEM stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments